Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients (Q44238473)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2002

Language	Label	Description	Also known as
English	Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients	scientific article published in December 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Catherine Jui-Ling Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yu-Chieh Ko

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ching-Yu Cheng

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Allen W Chiu

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Joe C Chou

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Wen-Ming Hsu

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jorn-Hon Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2241-2247

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Response of blood flow to warm and cold in normal and low-tension glaucoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of factors involved in the production of low tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic blood pressure in glaucoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pressure-dependent neuroretinal rim loss in normal-pressure glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive low-tension glaucoma: treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery for normal tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blocker eyedrops and nocturnal arterial hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a filtering procedure in low tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the prostanoid receptors and of the contractile effects of prostaglandin F2ain human pial arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(02)01247-2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44238473&oldid=2108842780"